Bindex® Commercialization & Development

About Bone Index

Bone Index is a commercial-stage diagnostics company focused on revolutionizing osteoporosis screening with its FDA-cleared and CE-marked Bindex® device. The technology offers a fast, accurate, and radiation-free alternative to traditional DXA scans, having conducted over 4 million scans globally with a reported 90% accuracy compared to DXA. Backed by over a decade of proprietary research and peer-reviewed studies, the company targets primary care, orthopedic clinics, and mobile screening services to enable earlier detection and management of osteoporosis. Its business model is based on the sale of its diagnostic devices and associated consumables.

Therapeutic Areas